These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23356287)

  • 1. Molecular mechanisms of platelet P2Y(12) receptor regulation.
    Cunningham MR; Nisar SP; Mundell SJ
    Biochem Soc Trans; 2013 Feb; 41(1):225-30. PubMed ID: 23356287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid resensitization of purinergic receptor function in human platelets.
    Mundell SJ; Barton JF; Mayo-Martin MB; Hardy AR; Poole AW
    J Thromb Haemost; 2008 Aug; 6(8):1393-404. PubMed ID: 18513210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARF6-dependent regulation of P2Y receptor traffic and function in human platelets.
    Kanamarlapudi V; Owens SE; Saha K; Pope RJ; Mundell SJ
    PLoS One; 2012; 7(8):e43532. PubMed ID: 22916275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Succinate reverses in-vitro platelet inhibition by acetylsalicylic acid and P2Y receptor antagonists.
    Spath B; Hansen A; Bokemeyer C; Langer F
    Platelets; 2012; 23(1):60-8. PubMed ID: 21736422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological consequences of receptor mistraffic: Tales from the platelet P2Y
    Cunningham MR; Aungraheeta R; Mundell SJ
    Mol Cell Endocrinol; 2017 Jul; 449():74-81. PubMed ID: 28212842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation in the P2Y12 receptor and a function-reducing polymorphism in protease-activated receptor 1 in a patient with chronic bleeding.
    Patel YM; Lordkipanidzé M; Lowe GC; Nisar SP; Garner K; Stockley J; Daly ME; Mitchell M; Watson SP; Austin SK; Mundell SJ
    J Thromb Haemost; 2014 May; 12(5):716-25. PubMed ID: 24612435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk.
    van der Meijden PE; Feijge MA; Giesen PL; Huijberts M; van Raak LP; Heemskerk JW
    Thromb Haemost; 2005 Jun; 93(6):1128-36. PubMed ID: 15968399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis.
    Conley PB; Delaney SM
    Curr Opin Hematol; 2003 Sep; 10(5):333-8. PubMed ID: 12913786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal cross-talk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human platelets.
    Hardy AR; Jones ML; Mundell SJ; Poole AW
    Blood; 2004 Sep; 104(6):1745-52. PubMed ID: 15187029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clopidogrel-insensitive inducible pool of P2Y12 receptors contributes to thrombus formation: inhibition by elinogrel, a direct-acting, reversible P2Y12 antagonist.
    Haberstock-Debic H; Andre P; Mills S; Phillips DR; Conley PB
    J Pharmacol Exp Ther; 2011 Oct; 339(1):54-61. PubMed ID: 21730013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the platelet ADP receptor targeted by antithrombotic drugs.
    Hollopeter G; Jantzen HM; Vincent D; Li G; England L; Ramakrishnan V; Yang RB; Nurden P; Nurden A; Julius D; Conley PB
    Nature; 2001 Jan; 409(6817):202-7. PubMed ID: 11196645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2Y12 receptor: platelet thrombus formation and medical interventions.
    Moheimani F; Jackson DE
    Int J Hematol; 2012 Nov; 96(5):572-87. PubMed ID: 23054651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of determinants required for agonistic and inverse agonistic ligand properties at the ADP receptor P2Y12.
    Schmidt P; Ritscher L; Dong EN; Hermsdorf T; Cöster M; Wittkopf D; Meiler J; Schöneberg T
    Mol Pharmacol; 2013 Jan; 83(1):256-66. PubMed ID: 23093496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms.
    Hardy AR; Conley PB; Luo J; Benovic JL; Poole AW; Mundell SJ
    Blood; 2005 May; 105(9):3552-60. PubMed ID: 15665114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SAR216471, an alternative to the use of currently available P2Y₁₂ receptor inhibitors?
    Delesque-Touchard N; Pflieger AM; Bonnet-Lignon S; Millet L; Salel V; Boldron C; Lassalle G; Herbert JM; Savi P; Bono F
    Thromb Res; 2014 Sep; 134(3):693-703. PubMed ID: 25064036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells.
    Gachet C
    Purinergic Signal; 2012 Sep; 8(3):609-19. PubMed ID: 22528678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
    Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
    Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intact PDZ motif is essential for correct P2Y12 purinoceptor traffic in human platelets.
    Nisar S; Daly ME; Federici AB; Artoni A; Mumford AD; Watson SP; Mundell SJ
    Blood; 2011 Nov; 118(20):5641-51. PubMed ID: 21937696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular Ca(2+) modulates ADP-evoked aggregation through altered agonist degradation: implications for conditions used to study P2Y receptor activation.
    Jones S; Evans RJ; Mahaut-Smith MP
    Br J Haematol; 2011 Apr; 153(1):83-91. PubMed ID: 21332705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biology and pharmacology of the platelet P2Y12 receptor.
    Storey RF
    Curr Pharm Des; 2006; 12(10):1255-9. PubMed ID: 16611109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.